Clin2
NCT06843629Possibly a fitRecruiting

PET scan test for MSLN in cancer patients

Ovarian CancerLung AdenocarcinomaPancreatic Cancer

Part of Cancer, Digestive system, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study uses a special PET scan to look for a protein called MSLN in certain cancers like pancreatic, ovarian, and lung cancer. It aims to see if this imaging method can help doctors understand your tumor better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You are 18 years old or older.
  • You have a known or suspected cancer like pancreatic, ovarian, or lung cancer.
  • You are able to lie still for a PET scan (no severe claustrophobia or fear of radiation).
  • You are not pregnant or breastfeeding.
  • If you are a woman who could become pregnant, you must use birth control before and during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07552467Recruiting
PET Imaging Scan for Detecting Cancer Using New Radioactive Tracer

This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.

Wuhan, Hubei
NCT07026981Not yet recruiting· Early Phase 1
PET scan study for new pancreatic and head and neck cancers

This trial uses a special PET scan tracer to see how it spreads in the body for people newly diagnosed with pancreatic or head and neck cancer who haven't had treatment yet. It aims to help doctors better understand and potentially treat these cancers.

Cleveland, Ohio
NCT05835570Recruiting
PET scan using an integrin marker to find cancer

This trial uses a special PET/CT scan that targets a protein on some cancer cells to help detect and evaluate malignant tumors. It may help doctors better map tumors before any cancer treatment starts.

Wuhan, Hubei
NCT06977945Recruiting
Testing FL-091 PET scans for cancer detection

This study tests a new imaging agent called FL-091 to see if it helps doctors find and stage cancers like head and neck, colorectal, or pancreatic cancer. You’ll get a PET scan that may give clearer pictures of tumors.

Wuhan, Hubei
NCT07301801Recruiting· Early Phase 1
New scan for detecting and staging certain cancers

This trial tests a new imaging agent (68Ga-FL-031) to see if it can help find and stage tumors in people with small cell lung cancer, breast cancer, nasopharyngeal cancer, or other cancers. The goal is to improve diagnosis and treatment planning.

Wuhan, Hubei
NCT07487883Recruiting
PET scan for lung cancer using a special tracer

This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.

Beijing, Beijing Municipality

Hear when a new Ovarian cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.